Parexel and NeoGenomics Collaborate in Precision Medicine
Parexel and NeoGenomics, Inc. have announced a partnership aiming to advance the application of precision medicine in oncology clinical trials by applying real-world genomics data.
The strategic partnership between Parexel and NeoGenomics will enable biopharmaceutical customers to make decisions regarding trial designs, companion diagnostics and drug repurposing as well as to build external control arms using genomic data. The companies are considering potential opportunities to expand the scope of the partnership, including lab services and biomarker capabilities.
For more information, click here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
